19 Kasım 2026, Perşembe · 20:01 Piyasalar Kapalı
borsapanel.com Borsanın nabzı, tek panelde.
Abone Ol

Travere Therapeutics' Outlook Brightens As Turnaround Looms

Biotech breakthroughs result in compelling turnaround stories, attracting stock investors well before the drug developers turn profitable. Losses during the second quarter did not deter investors from jumping into kidney drug provider Travere Therapeutics (TVTX) as they focused on its soaring sales and brightening outlook. Travere's shares executed a breakaway gap from a flat base at a pivot of 60.10…

Kaynak: Yahoo Finance
İlgili Haberler
Global Anthropic’s IPO poses this big risk to an already shaky stock market MarketWatch Top · 12 dk önce Global Moody’s upgrades Toyota outlook to positive, projects modest EBIT margin expansion Investing.com · 17 dk önce Global FCC votes to ban Chinese telecoms from direct access to US phone numbers Investing.com · 18 dk önce Global Earnings call transcript: Williams-Sonoma Q3 2026 beats EPS, stock falls 12% Investing.com · 21 dk önce Global Anthropic draws bullish Wall Street calls ahead of Nasdaq debut Investing.com · 23 dk önce

Yorumlar (0)

Giriş yaparak yorum yazabilirsin.

İlk yorumu sen yaz.